Delivery of genome-edited fertilized eggs (2-cell stage embryos), enabling affordable attempts at genome editing.
The genome editing fertilized egg production service provides only genome-edited mouse fertilized eggs as deliverables. Customers will implant the received genome-edited fertilized eggs into their own SPF mice, allowing for immediate F0 analysis at the customer's facility. 【Do you have any of the following requests?】 ■ Want to conduct genome editing experiments at a lower cost ■ Want to create knockout cells ■ Want to create disease model cells If you want to destroy existing genes and replace them with other genes, please consult us first. *We are currently offering materials comparing our services with those of other companies. For more details, please contact us or download the PDF to view.
Inquire About This Product
basic information
After target design at Setrotech, we will produce and freeze 100 mouse fertilized eggs (2-cell stage embryos) using the GEEP method (150 for the Gold Plan) and deliver them. In particular, the Gold Plan includes, in addition to the above, confirmation of gRNA cleavage, genetic sequence analysis of F0 offspring (up to 10), and a guarantee for the re-production of genome-edited fertilized eggs (one time), making it highly recommended!
Price information
For more details, please contact us or download the PDF to view.
Delivery Time
Applications/Examples of results
For more details, please contact us.
catalog（1）
Download All Catalogs
Company information
Setsurotech is a venture company founded in 2017 based on the technology and know-how cultivated at Tokushima University. Ryuuya Takemoto (Chairman and CTO) and others from Tokushima University developed a method in 2015 for easily and efficiently creating genome-edited mice (Patent No. 6980218). Additionally, Toshiyuki Sawatsubashi (Director and CSO) from Tokushima University developed the VIKING method, which achieves high-efficiency genome editing in cultured cells (Patent No. 6956995). Furthermore, they have developed a unique new genome editing factor, ST8 (Patent No. 7113415), and are advancing research and development to accelerate breeding improvements in agriculture and livestock, in addition to the medical field. Setsurotech utilizes these unique technologies to offer genome editing contract services for researchers in academia and industry, as well as to broadly provide genome-edited organisms to the industrial sector, aiming to develop the genome editing industry through the PAGEs (Platform Application using Genome Editing by Setsurotech) initiative. With the vision of making Tokushima the birthplace of the genome editing industry, we are committed to contributing to the local industry.